Dewnani
Jay Dewnani, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20090186657 | Subscriber identity module (SIM) card access system and method - An electronic device comprises a controller coupled to a switch and configured to control actuation of the switch to enable at least two different modules of the electronic device to access content stored on a subscriber identity module (SIM) card based on a communications module operating configuration for the electronic device. | 07-23-2009 |
Sunita V. Dewnani, Secaucus, NJ US
Patent application number | Description | Published |
---|---|---|
20110281795 | GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE - Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included. | 11-17-2011 |
20150018399 | GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE - Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included. | 01-15-2015 |
20150336991 | NOVEL GLUCOKINASE ACTIVATOR COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS, AND METHODS OF TREATMENT - Novel pyridine-2-carboxamide derivatives of formula I: and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. The compounds are effective as glucokinase activating agents. Pharmaceutical compositions and methods of treatment are also included. | 11-26-2015 |
Sunita V. Dewnani, Rahway, NJ US
Patent application number | Description | Published |
---|---|---|
20150336991 | NOVEL GLUCOKINASE ACTIVATOR COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS, AND METHODS OF TREATMENT - Novel pyridine-2-carboxamide derivatives of formula I: and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. The compounds are effective as glucokinase activating agents. Pharmaceutical compositions and methods of treatment are also included. | 11-26-2015 |